PrEP - Pre-exposure prophylaxis
Mar 26, 2021
Seneviratne HK, Tillotson J, Lade JM, Bekker LG, Li S, Pathak S, Justman J, Mgodi N, Swaminathan S, Sista N, Farrior J, Richardson P, Hendrix CW, Bumpus NN. AIDS Res Hum Retroviruses. 2021 Mar;37(3):173-183. doi: 10.1089/AID.2020.0155. Epub 2021 Jan 13. PMID:...
Nov 18, 2020
Article and Study Summary: Community-based antiretroviral therapy versus standard clinic-based services for HIV in South Africa and Uganda (DO ART): a randomised trial. Published in: Lancet Glob Health. 2020;8(10):e1305-e1315....
Aug 25, 2020
Article and Study Summary: Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): Primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority...
May 8, 2020
Colson PW, Franks J, Wu Y, Winterhalter FS, Knox J, Ortega H, El-Sadr WM, Hirsch-Moverman Y. [published online ahead of print, 2020 May 8]. AIDS Behav. 2020;10.1007/s10461-020-02901-6. doi:10.1007/s10461-020-02901-6 Abstract While oral pre-exposure prophylaxis...
Feb 28, 2020
Djomand G, Bingham T, Benech I, Muthui M, Savva H, Alamo S, Manopaiboon C, Wheeler T, Mital S. MMWR Morb Mortal Wkly Rep. 2020 Feb 28;69(8):212-215. doi: 10.15585/mmwr.mm6908a3. Abstract The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), the...